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A B S T R A C T
Expression of the mTORC1 repressor, Regulated in DNA Damage and Development 1 (REDD1), is elevated in
skeletal muscle during various catabolic conditions including fasting, hindlimb immobilization, and sepsis.
Conversely, REDD1 expression is suppressed by anabolic stimuli such as resistance exercise or nutrient
consumption following a fast. Though it is known that nutrient consumption reduces REDD1 expression, it is
largely unknown how nutrients and hormones individually contribute to the reduction in REDD1 expression.
Therefore, the purpose of the present study was to determine how nutrients and hormones individually regulate
REDD1 expression. HeLa cells were deprived of leucine or serum for 10 h, after which either leucine or serum
was reintroduced to cell culture medium for 60 min. Re-supplementation of either leucine or serum resulted in a
reduction in REDD1 protein levels by 34.8 ± 5.8% and 54.1 ± 3.4%, respectively, compared to the deprived
conditions. Re-supplementation of leucine or serum to deprived cells also led to a reduction in REDD1 mRNA
content by 49.1 ± 2.7% and 65.0 ± 1.4%, respectively, compared to the deprived conditions. Interestingly, rates
of REDD1 protein degradation were unaﬀected by either leucine or serum re-supplementation, as assessed in
cells treated with cycloheximide to block protein synthesis. Likewise, addition of leucine- or serum to cells
treated with Actinomycin D to inhibit gene transcription failed to alter the rate of REDD1 mRNA degradation.
The data indicate that the leucine or serum-induced suppression of REDD1 expression occurs independent of
changes in the rate of degradation of either the REDD1 protein or mRNA. Thus, the leucine- or serum-induced
suppression likely occurs through alternative mechanism(s) such as reduced REDD1 gene transcription and/or
mRNA translation.
1. Introduction
Single- and multi-cellular organisms have evolved unique nutrient
sensing mechanisms that allow them to quickly respond to the ever-
changing nutrient status in their extracellular environment. This
bestows upon them the ability to respond to conditions in which
anabolic stimuli trigger intracellular signaling cascades that promote
cellular growth and proliferation. Conversely, catabolic conditions
trigger speciﬁc intracellular signals that are growth restrictive and
promote energy conservation [1]. Integration of a variety of cellular
stimuli including hormone and nutrient availability to regulate various
cellular processes such as mRNA translation and ribosome biogenesis
is mediated through phosphorylation of downstream substrates, e.g.
p70S6K1 on Thr389 [2], by a serine/threonine protein kinase referred
to as the mechanistic target of rapamycin in complex 1 (mTORC1).
Two independent pathways consisting of 1) anabolic hormone signal-
ing (i.e. insulin and IGF-1) that activates the GTPase, ras-homolog
enriched in brain (Rheb) [3], and 2) nutrient sensing mechanisms like
the Rag GTPases [4], work in coordination for complete activation of
mTORC1 signaling.
Activation of downstream anabolic pathways by mTORC1 is
energetically demanding [5] and thus during catabolic or stressful
conditions cells have evolved mechanisms to govern its activation state.
Regulated in Development and DNA Damage (REDD1) functions as an
upstream repressor of mTORC1 signaling and is upregulated under
various catabolic conditions including long-term nutrient deprivation
[6–9]. Alternatively, REDD1 expression is rapidly suppressed upon
refeeding a previously fasted animal in association with activation of
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mTORC1 signaling [10]. A common mechanism of REDD1 expression
under the aforementioned conditions is through induction of the
endoplasmic reticulum (ER) stress response, which allows for the
translation of select transcripts, including activating transcription
factor 4 (ATF4), leading to REDD1 mRNA and protein expression
[11]. Our group has previously demonstrated that ATF4 is necessary
and suﬃcient for the ER stress induced induction of REDD1 mRNA
and protein expression [12].
A recent report demonstrates that REDD1 also plays a role in
limiting the nutrient-induced stimulation of protein synthesis [10].
Accordingly, REDD1 is a critical regulator of the cellular response to
nutrient status. Understanding the factors that regulate intracellular
processes related to fasting and re-feeding will be critical in expanding
our knowledge of the intimate relationship between the cellular
response to fasting and re-feeding and may provide insight into
contributors of metabolic disease development and progression.
While most studies have focused on conditions of REDD1 induction
and its mechanism of action, very few have investigated the factors
contributing to the resolution of REDD1 mRNA or protein expression.
Therefore, the goal of the present study is to further understand the
regulation of REDD1 mRNA and protein expression in response to in
vitro deprivation and re-supplementation of either leucine or serum,
two potent activators of mTORC1.
2. Materials and methods
2.1. Cell culture
HeLa cells (ATCC, Manassas, VA, Cat. # CCL-2) were maintained in
culture at 37 °C in a humidiﬁed incubator with 5% CO2 in high glucose
Dulbecco's modiﬁed Eagle's Medium (DMEM, Invitrogen, Carlsbad,
CA) with 10% fetal bovine serum (Atlas Biologicals, Fort Collins, CO)
and 1% penicillin-streptomycin (Invitrogen). On the day of the experi-
ment, cells were placed in serum-free medium (DMEM) or leucine-free
medium (Atlanta Biologicals, Lawrenceville, GA) for 10 h. After 10 h of
starvation, 10% serum or 0.76 mM leucine (Sigma, St. Louis, MO) was
re-introduced into the culture medium for the indicated times. For
experiments using Actinomycin D (Sigma) or cycloheximide (A.G.
Scientiﬁc, San Diego, CA), cells were prepared as described above with
the exception that either Actinomycin D (2 μg/mL) or cycloheximide
(100 μg/mL) was added to the medium for 15 min or 2 min, respec-
tively, prior to the re-introduction of serum or leucine.
2.2. RNA isolation and quantitative real-time PCR
Cells were treated as described above and total RNA was extracted
with TRIzol reagent according to the manufacturer's protocol
(Invitrogen). RNA (1 μg) was reverse transcribed using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA) and subjected to quantitative real-time PCR using
QuantiTect SYBR Green master mix (Qiagen, Germantown, MD).
Human speciﬁc primers used for ampliﬁcation of REDD1 and
Fig. 1. Prolonged leucine and serum deprivation increase REDD1 protein and mRNA expression. HeLa cells were deprived of leucine (A, C) or serum (B, D) for varying times up to 10 h.
(A, B) Phosphorylation of p70S6K1 on T389 and REDD1 protein was assessed by Western blot analysis. REDD1 mRNA abundance (C, D) was assessed by SYBR Green qRT-PCR and
normalized to GAPDH. Results represent the mean ± SEM of 3 independent experiments with 2 replicates performed in each experiment. Experimental groups with means that are
statistically diﬀerent from one another are indicated with diﬀerent letters above the bars (One-Way ANOVA and Tukey's post hoc test for multiple comparisons, p < 0.05).
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GAPDH mRNA were previously described [12]. Mean cycle threshold
(CT) values for REDD1 and GAPDH were determined for control and
experimental samples. Changes in REDD1 mRNA expression levels
were normalized to GAPDH mRNA expression using the 2 C−∆∆ T
calculations as previously described [13].
2.3. Western blot analysis
Cells were treated as described above, washed once in phosphate-
buﬀered saline, lysed and harvested in Laemmli sample buﬀer, and
boiled for 5 min. An equal volume of each sample was fractionated by
SDS-PAGE using Bio-Rad precast Criterion gels (Bio-Rad, Hercules,
CA). Fractionated samples were transferred onto PVDF membranes
and blocked for 1 h with 5% nonfat dry milk (NFDM) in Tris-buﬀered
saline with 0.1% Tween20 (TBST). Membranes were incubated over-
night at 4 °C with one of the following primary antibodies: anti-REDD1
(ProteinTech Group Inc., Chicago, IL, Cat. # 10638), p70S6K1 T389
(Cell Signaling, Danvers, MA, Cat. # 9205), alpha-Tubulin (Santa Cruz,
Dallas, TX, Cat. # sc-32293). Membranes were incubated with appro-
priate horseradish peroxidase-conjugated secondary antibody (Bethyl,
Montgomery, TX) in 5% NFDM in TBST at room temperature for one
hour then washed thrice in TBST. Blots were developed with ECL Plus
reagents (Bio-Rad, Hercules, CA) using a FluorChem M Multiﬂuor
System (ProteinSimple, San Jose, CA). Western blot densitometry was
quantitated using Image J Software (National Institutes of Health).
2.4. Statistics
Data are expressed as the mean ± standard error of the mean
(SEM). Statistical analyses are described within the ﬁgure legends.
Statistical signiﬁcance was set at p < 0.05.
3. Results
As an in vitro experimental model of an overnight fast, HeLa cells
were deprived of leucine or serum for up to 10 h prior to quantitation
of REDD1 expression by Western blot analysis. REDD1 expression in
leucine-deprived cells exhibited a bi-phasic response, with an initial
drop in expression during the ﬁrst 2 h of deprivation followed by a
subsequent, prolonged increase in expression (Fig. 1A). The response
to serum deprivation exhibited a similar biphasic response (Fig. 1B).
The time course of leucine- or serum-deprivation induced changes in
REDD1 mRNA expression temporally mirrored those for the protein
(Fig. 1C and D, respectively). Consistent with previous reports [10,14],
elevated REDD1 protein expression was associated with a concomitant
reduction in signaling through mTORC1 as assessed by reduced
phosphorylation of p70S6K1 on T389 (Fig. 1A, B). Upon re-supple-
mentation of either leucine or serum to a ﬁnal concentration of
0.76 mM or 10%, respectively, for one hour, REDD1 protein expression
was reduced by 34.8 ± 5.8% and 54.1 ± 3.4% respectively, compared to
the deprived conditions (Fig. 2A, B). As expected, the reduction in
REDD1 protein expression was associated with an increase in phos-
phorylation of p70S6K1 on T389 (Fig. 2A, B). Interestingly, re-
supplementation of either leucine or serum also led to a reduction in
REDD1 mRNA expression by 49.1 ± 2.7% and 65.0 ± 1.4%, respec-
tively, compared to the deprived conditions (Fig. 2C, D).
We next sought to evaluate the rate of REDD1 protein turnover in
the presence or absence of leucine or serum. Previous reports have
demonstrated that the half-life of the endogenous REDD1 protein is
approximately ﬁve minutes [15] while ectopically expressed REDD1
Fig. 2. Leucine and serum re-supplementation increase mTORC1 signaling and reduce REDD1 protein and mRNA expression. HeLa cells were deprived of leucine (A, C) or serum (B,
D) for 10 h after which leucine or serum were added to the respective culture media to a ﬁnal concentration of 0.76 mM or 10%, respectively. (A, B) Phosphorylation of p70S6K1 on T389
and REDD1 protein was assessed by Western blot analysis. REDD1 mRNA abundance (C, D) was assessed by SYBR Green qRT-PCR and normalized to GAPDH. Results represent the
mean ± SEM of 3 independent experiments with 2 replicates performed in each experiment. In panels A and B linear regression was performed for visualization of the decline in REDD1
expression. In panels C and D, experimental groups with means that are statistically diﬀerent from one another are indicated with diﬀerent letters above the bars (One-Way ANOVA and
Tukey's post hoc test for multiple comparisons, p < 0.05).
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protein has a half-life of approximately 30 min [16]. With such a
relatively short half-life it is possible that REDD1 protein expression is
controlled through mechanisms that regulate its stability. To assess
whether REDD1 protein stability is altered in the presence or absence
of leucine or serum, cycloheximide was added to the culture medium to
block de novo protein synthesis. Consistent with previous results, the
half-life of REDD1 protein was approximately 10 min and there were
no signiﬁcant diﬀerences in its rate of turnover between cells main-
tained in the presence or absence of leucine or serum (Fig. 3A and B).
These data demonstrate that REDD1 protein degradation is not
aﬀected by the re-supplementation of leucine or serum to cells in
culture.
It is also possible that REDD1 mRNA expression is regulated post-
transcriptionally. To investigate if the leucine- or serum-induced
reductions in REDD1 mRNA expression were due to diﬀerences in
mRNA degradation, the transcriptional inhibitor, actinomycin D, was
added to HeLa cells in the presence or absence of leucine or serum.
Similar to results obtained regarding protein stability, re-supplementa-
tion of culture medium with 0.76 M leucine led to no signiﬁcant
diﬀerence in the rate of REDD1 mRNA degradation when compared to
leucine deprived cells (Fig. 4C). Likewise, no signiﬁcant diﬀerence was
observed when 10% serum was re-introduced to the culture medium
compared to serum deprived cells (Fig. 4D). These data are consistent
with previous reports wherein REDD1 mRNA half-life is approximately
30–60 min, depending on culture conditions [17]. Interestingly, under
the aforementioned conditions, REDD1 protein expression mirrored
REDD1 mRNA expression regardless of the presence or absence of
leucine or serum (Fig. 4 A, B), demonstrating that neither REDD1
mRNA nor protein degradation rate is aﬀected by the re-supplementa-
tion of leucine or serum to cells in culture.
4. Discussion
Quickly sensing changes in the extracellular milieu and responding
accordingly by altering gene transcription and mRNA translation is
critical to the ability of cells to maintain homeostasis during various
stressful conditions. Under conditions of nutritional stress, nutrient
sensing mechanisms exist to divert resources away from energy
consuming to energy conserving processes, a hallmark of the integrated
stress response (ISR) [18].
While very little has been done with regard to understanding the
post-translational regulation of REDD1, a recent study showed that
GSK3β phosphorylates REDD1 at T23/25 and that the half-life of a
REDD1 variant in which T23/25 are mutated to Ala is signiﬁcantly
longer compared to the wild type protein [16]. These ﬁndings suggest
that phosphorylation of REDD1 by GSK3β results in its destabilization.
However, re-addition of growth factors to serum starved cells in culture
activates the phosphatidylinositol 3-kinase (PI3K)/AKT signaling cas-
cade resulting in an inhibitory phosphorylation of GSK3β [19]. Thus,
readdition of serum to serum-deprived cells would repress GSK3β
activity, resulting in stabilization of REDD1. However, we show that
there are no diﬀerences in rates of REDD1 protein degradation in the
presence or absence of serum, suggesting that the eﬀect of GSK3β did
not play a role in the stabilization of REDD1 under conditions of serum
deprivation and re-supplementation in the present study.
The data regarding post-transcriptional regulation of REDD1 is also
very limited, but several groups have shown that microRNA's (miR)
play a role in the regulation of REDD1 expression. For example,
ectopically expressed miR-495 can directly suppress REDD1 expres-
sion by binding to the 3'-untranslated region of REDD1 mRNA. This
led to an approximate 40% reduction in both REDD1 mRNA and
protein expression that contributes to the resistance of breast cancer
stem cells to hypoxia [20]. Similar results were obtained in a model of
gamma-irradiated hematopoetic and osteoblastic cells, where gamma-
irradiation induced upregulation of miR-30c and its overexpression led
to a reduction in REDD1 expression. A potential binding site for miR-
30c was also identiﬁed in the 3'-UTR of the REDD1 gene [21]. These
data demonstrate diﬀerential expression of miRNA's under distinct
physiological and pathological conditions and suggest that novel
mechanisms of REDD1 suppression exist to promote cell survival
Fig. 3. Leucine and serum do not alter the rate of REDD1 protein degradation. HeLa cells were deprived of leucine (A) or serum (B) for 10 h. The cell culture medium was then
supplemented with cycloheximide to a ﬁnal concentration of 100 μg/mL, and two minutes later one-half of the cells in leucine-free medium (LFM) were supplemented with leucine and
one-half of the cells in serum-free medium (SFM) were supplemented with serum to ﬁnal concentrations of 0.76 mM or 10%, respectively. Samples were collected immediately before
cycloheximide addition and at three-minute intervals after the re-addition of leucine or serum. REDD1 protein was assessed by Western blot analysis. Non-linear regression using one-
phase decay and least squares ﬁt of each condition; results represent the mean ± SEM of 3 independent experiments with 2 replicates performed in each experiment. R2 values with and
without leucine are 0.9442 and 0.9316, respectively. R2 values with and without serum are 0.8772 and 0.9116, respectively.
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and will likely warrant further investigation. Though we cannot
speculate on the post-transcriptional repression of REDD1 by
miRNAs under the conditions of leucine and serum deprivation used
in this study, their role should not be discounted.
The results of the present study corroborate previous ﬁndings that
REDD1 induction is a consequence of nutritional stress through serum
deprivation [6] and extend those data to show leucine deprivation
alone can induce REDD1 protein expression. They also show that re-
addition of either leucine or serum to the culture medium restores
REDD1 mRNA and protein expression to near baseline levels within
one hour. Given that REDD1 mRNA levels decline at a similar rate in
the presence or absence of the transcriptional inhibitor, actinomycin D
(Fig. 2C, D vs Fig. 4C, D), and the extraordinarily short half-life of
REDD1 protein (Fig. 3), these data suggest that REDD1 is largely
regulated by rates of transcription. This idea is also supported by a
similar decline in REDD1 protein expression during a one-hour
actinomycin D treatment independent of the presence or absence or
leucine or serum (Fig. 4A, B). Frost and colleagues reported a similar
ﬁnding where the insulin-like growth factor 1-induced increase in
REDD1 mRNA and protein required new transcription and translation
of the REDD1 gene and mRNA [22]. In a recent publication from our
laboratory, REDD1+/+ mice refed for 15 min after an overnight fast
showed no noticeable decreases in REDD1 protein expression, whereas
60 min of refeeding was suﬃcient to reduce REDD1 protein expression
[10]. It is tempting to speculate that even though REDD1 gene
transcript may have been repressed in mice refed for 15 min, insuﬃ-
cient time had elapsed to allow for a detectable change in the amount of
the protein. In contrast, by 60 min of refeeding, mRNA levels had
declined allowing changes in expression of the protein to be detected.
Further support for the idea that REDD1 is primarily regulated through
rates of transcription is obtained from studies in skeletal muscle of
hindlimb-immobilized rats that were fasted overnight and later admi-
nistered an oral dose of either saline or leucine as a nutrient stimulus.
Accordingly, REDD1 mRNA was elevated in soleus muscle as soon as
one day following immobilization and continued to increase at day two
and three post-immobilization. Interestingly, 15 min after receiving an
oral gavage of leucine REDD1 mRNA levels were signiﬁcantly lower
compared to their respective controls, regardless of the rat's immobi-
lization status [8].
Experimental approaches to investigate rates of REDD1 gene
transcription and mRNA translation were unsuccessful. We hypothe-
size that the relatively low abundance and short half life of REDD1
mRNA and protein combined with REDD1's potent inhibitory eﬀects
on protein synthesis makes it problematic to determine in vitro
conditions that are amicable to study its rate of transcription or
translation. However, the tight association between leucine- and
serum-induced changes in REDD1 mRNA and protein expression
strongly suggest that regulation of gene expression plays a key role in
controlling REDD1 protein expression. Thus, it seems reasonable to
conclude that during times of nutrient deplete conditions either
through leucine- or serum-deprivation, induction of the ISR leads to
a concomitant induction of REDD1 mRNA and protein expression and
repletion of nutrients by re-addition of leucine or serum to the culture
medium resolves the stress allowing for a reduction in REDD1
transcription. Combined, these data suggest that the leucine- or
serum-induced suppression of REDD1 expression occurs independent
of rates of degradation of the REDD1 protein or mRNA and suggest a
mechanism in which REDD1 expression is primarily controlled
through rates of transcription.
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